DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 071846
NDA 071846 describes NITROGLYCERIN IN DEXTROSE 5%, which is a drug marketed by Baxter Hlthcare and Hospira and is included in five NDAs. It is available from one supplier. Additional details are available on the NITROGLYCERIN IN DEXTROSE 5% profile page.
The generic ingredient in NITROGLYCERIN IN DEXTROSE 5% is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
The generic ingredient in NITROGLYCERIN IN DEXTROSE 5% is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
Summary for 071846
| Tradename: | NITROGLYCERIN IN DEXTROSE 5% |
| Applicant: | Hospira |
| Ingredient: | nitroglycerin |
| Patents: | 0 |
| Therapeutic Class: | Cardiovascular Agents |
| Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 071846
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/100ML | ||||
| Approval Date: | Aug 31, 1990 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
